Hester Biosciences Limited — Others, 28-04-2025: Disclosure under SEBI Takeover Regulations

Hester Biosciences has received a declaration from Mr. Rajiv Gandhi, representing the promoters and promoters group, confirming that there have been no encumbrances on their shareholding during the financial year ending 31 March 2025. This update suggests continued stability in the ownership structure, which is likely to enhance investor confidence. The lack of encumbrances may signal a positive outlook for governance and financial health, potentially reducing perceived risk for shareholders. Overall, this update reflects a commitment to transparency and could foster a favorable sentiment among investors.